Nanalysis Announces Third Quarter 2023 Conference Call

Rhea-AI Summary

Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1) announces a conference call to discuss the results for the quarter ending September 30, 2023, on November 29th, 2023, at 5:00 P.M. Eastern Time. Chief Executive Officer Sean Krakiwsky and Chief Financial Officer Randall McRae will lead the call, which will be available for investors to join via phone or online. Additionally, a Q&A session for European investors will be held on November 30th at 8:30am ET.

Hosting Call at 5:00 pm ET on Wednesday, November 29th

European Q&A Session on November 30th at 8:30am ET

CALGARY, AB, Nov. 15, 2023 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications announces that on Wednesday, November 29th, 2023, the Company will put out a press release and Chief Executive Officer Sean Krakiwsky and Chief Financial Officer Randall McRae will host a conference call at 5:00 P.M. Eastern Time to discuss the results for the quarter ending September 30, 2023. 

Investors interested in participating in the live full year call can dial 1-888-664-6392 or 416-764-8659 from abroad. Investors can also access the call online through a listen-only webcast here:  https://app.webinar.net/r3VaMyOQbg1 or on the investor relations section of the Company's website HERE.

The webcast will be archived on the Company's investor relations webpage for at least 90 days and a telephonic playback will be available for seven days after the conference call by calling 1-888-390-0541 or 416-764-8677, conference ID # 964847.

Additionally, the Company will be hosting a Q&A session for it's European investors at 8:30am ET on Thursday, November 30th which can be accessed by the following link:  Click here to join the meeting.

About Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF, FRA:1N1)

Nanalysis' business is what we term "MRI and NMR for industry". The Company develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers or analyzers for laboratory and industrial markets. The NMReady-60™ was the first full-feature portable NMR spectrometer in a single compact enclosure requiring no liquid helium or any other cryogens. The Company has followed-up that initial offering with new products and continues to have a strong innovation pipeline. In 2020 Nanalysis announced the launch of its100MHz device, the most powerful and most advanced compact NMR device ever brought to market.

Nanalysis' devices are used in many industries (oil and gas, chemical, mining, pharma, biotech, flavor and fragrances, agrochemicals, law enforcement, and more) as well as numerous government and university research labs around the world. The Company continues to exploit new global market opportunities independently and with partners.

In 2022 the Company acquired K'(Prime) Technologies Inc. (K'Prime), a North American sales and service company which provides sales services for scientific instrumentation for pharma, food, chemical and oil & gas customers, as well as imaging systems for security applications.  K'Prime's service organization provides airport and commercial security installation and maintenance solutions across North America.

Additionally in 2022, the Company acquired a 43% ownership in Quad Systems AG ("Quad Systems"), a Zurich-based Nuclear Magnetic Resonance (NMR) company focused on high-field NMR for pharmaceutical and other vertical markets.

Notice regarding Forward Looking Statements and Legal Disclaimer

This news release contains certain "forward-looking statements" within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as "anticipates", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

View original content to download multimedia:https://www.prnewswire.com/news-releases/nanalysis-announces-third-quarter-2023-conference-call-301988734.html

SOURCE Nanalysis Scientific Corp.

FAQ

When is the conference call to discuss the quarterly results?

The conference call will be held on November 29th, 2023, at 5:00 P.M. Eastern Time.

Who will lead the conference call?

Chief Executive Officer Sean Krakiwsky and Chief Financial Officer Randall McRae will lead the call.

How can investors join the conference call?

Investors can dial 1-888-664-6392 or 416-764-8659 from abroad, or access the call online through a listen-only webcast.

Will the conference call be available for playback?

Yes, the webcast will be archived on the Company's investor relations webpage for at least 90 days, and a telephonic playback will be available for seven days after the conference call.

When is the Q&A session for European investors?

The Q&A session will be held on November 30th at 8:30am ET.